Breaking the barriers: Overcoming cancer resistance by targeting the NLRP3 inflammasome. Far NP, Varnousafaderani MH, Faghihkhorasani F, et al. Breaking the barriers: Overcoming cancer resistance by targeting the NLRP3 inflammasome. British journal of pharmacology. 2024. doi:10.1111/bph.17352 Read more